Targeting TGF-β signal transduction for fibrosis and cancer therapy

D Peng, M Fu, M Wang, Y Wei, X Wei - Molecular cancer, 2022 - Springer
Transforming growth factor β (TGF-β) has long been identified with its intensive involvement
in early embryonic development and organogenesis, immune supervision, tissue repair, and …

Transforming growth factor-β signaling: from tissue fibrosis to therapeutic opportunities

LL Ren, XJ Li, TT Duan, ZH Li, JZ Yang… - Chemico-biological …, 2023 - Elsevier
Fibrosis refers to the excessive deposition of extracellular matrix components in the
processes of wound repair or tissue regeneration after tissue damage. Fibrosis occurs in …

TGF-β signaling: from tissue fibrosis to tumor microenvironment

JYF Chung, MKK Chan, JSF Li, ASW Chan… - International Journal of …, 2021 - mdpi.com
Transforming growth factor-β (TGF-β) signaling triggers diverse biological actions in
inflammatory diseases. In tissue fibrosis, it acts as a key pathogenic regulator for promoting …

Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential

PS Tsou, J Varga, S O'Reilly - Nature Reviews Rheumatology, 2021 - nature.com
Systemic sclerosis (SSc) is a prototypical inflammatory fibrotic disease involving
inflammation, vascular abnormalities and fibrosis that primarily affect the skin and lungs. The …

TGF‐β Signaling: A Recap of SMAD‐independent and SMAD‐dependent Pathways

S Aashaq, A Batool, SA Mir, MA Beigh… - Journal of cellular …, 2022 - Wiley Online Library
Transforming growth factor‐β (TGF‐β) is a proinflammatory cytokine known to control a
diverse array of pathological and physiological conditions during normal development and …

[PDF][PDF] One year in review 2021: systemic sclerosis

M Di Battista, S Barsotti, M Orlandi, G Lepri… - Clin Exp …, 2021 - clinexprheumatol.org
Systemic sclerosis is a rare and chronic connective tissue disease with a multifaceted
pathogenesis characterised by heterogeneous multi-organ clinical manifestations. Every …

Roles of lipid metabolism and its regulatory mechanism in idiopathic pulmonary fibrosis: A review

Y Tian, C Duan, J Feng, J Liao, Y Yang… - The International Journal of …, 2023 - Elsevier
Idiopathic pulmonary fibrosis is a progressive lung disease of unknown etiology
characterized by distorted distal lung architecture, inflammation, and fibrosis. Several lung …

[HTML][HTML] PM2. 5 triggers autophagic degradation of Caveolin-1 via endoplasmic reticulum stress (ERS) to enhance the TGF-β1/Smad3 axis promoting pulmonary …

H Liu, W Lai, H Nie, Y Shi, L Zhu, L Yang, L Tian… - Environment …, 2023 - Elsevier
Air pollution is highly associated with respiratory diseases. However, the influence and
mechanism of particulate matter with aerodynamic equal to or less than 2.5 μm (PM 2.5) in …

Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesis

Y Qiu, M Xu, S Huang - Blood, The Journal of the American …, 2021 - ashpublications.org
Genome-wide analyses have revealed that long noncoding RNAs (lncRNAs) are not only
passive transcription products, but also major regulators of genome structure and …

Integrative small and long RNA omics analysis of human healing and nonhealing wounds discovers cooperating microRNAs as therapeutic targets

Z Liu, L Zhang, MA Toma, D Li, X Bian, I Pastar… - Elife, 2022 - elifesciences.org
MicroRNAs (miR), as important epigenetic control factors, reportedly regulate wound repair.
However, our insufficient knowledge of clinically relevant miRs hinders their potential …